REFERENCES
- Coffin CM, Dehner LP. Fibroblastic-myofibroblastic tumors in children and adolescents: a clinicopathologic study of 108 examples in 103 patients. Pediatr Pathol. 1991; 11: 569–588. [PUBMED], [INFOTRIEVE]
- Coffin CM, Dehner LP. Soft tissue tumors in first year of life: a report of 190 cases. Pediatr Pathol. 1990; 10: 509–526. [PUBMED], [INFOTRIEVE]
- Coffin CM, Dehner LP. Pathologic evaluation of pediatric soft tissue tumors. Am J Clin Pathol. 1998; 109(4 Suppl 1)S38–S52. [PUBMED], [INFOTRIEVE], [CSA]
- Fletcher CDM, Unni KK, Mertens F. Fibroblastic/myofibroblastic tumors. Fletcher CDM, Unni KK, Mertens F. Tumours of Soft Tissue and Bone. LyonFrance, IARC Press. 2002; 47–108
- Coffin CM, Jaszcz W, O'Shea PA, Dehner LP. So-called congenital-infantile fibrosarcoma: does it exist and what is it?. Pediatr Pathol. 1994; 14: 133–150. [PUBMED], [INFOTRIEVE]
- Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumor: congenital (infantile) fibrosarcoma and mesoblastic nephroma. Cancer Genet Cytogenet. 2002; 132: 1–13. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wherli BM, Weiss SW, Yandow S, Coffin CM. Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. Am J Surg Pathol. 2001; 25: 645–651. [CSA], [CROSSREF]
- Joshi VJ, Balarezo F, Hicks MJ, Mierau GW, Tsongalis GJ. Approach to small round cell tumors of childhood. Pathol Case Rev. 2000; 5: 26–41
- Trobs RB, Meier R, Bennek J, Heinrich S, Willnow U. Fibrosarcoma in infants and children: a retrospective analysis—overdiagnosis in early years. Pediatr Surg Int. 1999; 15: 123–128. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cecchetto G, Carli M, Alaggio R, et al, Italian Cooperative Group. Fibrosarcoma in pediatric patients: results of the Italian Cooperative Group studies (1975-1995). J Surg Oncol. 2001; 78: 225–231. [PUBMED], [INFOTRIEVE], [CROSSREF]
- O, Malley DP, Mierau GW, Beckwith JB, Weeks DA. Ultrastructure of cellular mesoblastic nephroma. Ultrastruct Pathol. 1996; 20: 417–427. [CSA]
- Loeb DM, Hill DA, Dome JS. Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy. J Pediatr Hematol Oncol. 2002; 24: 478–481. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shetty AK, Yu LC, Gardner RV, Warrier RP. Role of chemotherapy in the treatment of infantile fibrosarcoma. Med Pediatr Oncol. 1999; 33: 425–427. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Loh ML, Ahn P, Perez-Atayde AR, Gebhardt MC, Shamberger RC, Grier HE. Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children's Hospital, Boston. J Pediatr Hematol Oncol. 2002; 24: 722–726. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McCahon E, Sorensen PHB, Davis JH, Rogers PCJ, Schultz KR. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. Med Pediatr Oncol. 2003; 40: 288–292. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Adem C, Gisselsson D, Cin PD, Nascimento AG. ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescence in situ hybridization. Mod Pathol. 2001; 14: 1246–1251. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Argani P, Fritsch M, Kadkol SS, Schuster A, Beckwith JB, Perlman EJ. Detection of ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol. 1999; 13: 29–36. [CSA], [CROSSREF]
- Bourgeois JM, Knezevich SR, Mathers JA, Sorensen PHB. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma form other childhood spindle cell tumors. Am J Surg Pathol. 2000; 24: 937–946. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Knezevich SR, McFadden DE, Tao W, Lim JF. Sorensen PH: A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998; 18: 184–187. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Behar PM, Albritton FD, Muller S, Todd NW. Multicentric infantile myofibromatosis. Int J Pediatr Otorhinolarngol. 1998; 45: 249–254. [CROSSREF]
- Netscher DT, Eladoumikdachi F, Popek EJ. Infantile myofibromatosis; case report of a solitary hand lesion with emphasis on differential diagnosis and management. Ann Plast Surg. 2001; 46: 62–67. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ikediobi NI, Iyengar V, Hwang L, Collins WE, Metry DW. Infantile myofibromatosis: support for autosomal dominant inheritance. J Am Acad Dermatol. 2003; 49: S148–S150. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mentzel T, Calonje E, Nascimento AG, Fletcher CDM. Infantile hemangiopericytoma versus infantile myofibromatosis: study of a series suggesting a continuous spectrum of infantile myofibroblastic lesions. Am J Surg Pathol. 1994; 18: 922–930. [PUBMED], [INFOTRIEVE]
- Variend S, Bax NMA, Van Gorp J Are infantile myofibromatosis, congenital fibrosarcoma and congenital haemangiopericytoma histogenetically related?. Histopathology. 1995; 26: 57–62. [PUBMED], [INFOTRIEVE], [CSA]
- Dahlen A, Fletcher CDM, Mertens F, et al, Activation of the GLI oncogene through fusion with the beta-actin (ACTB) gene in a group of pericytic tumor with t(7; 12): pericytoma with (t7;12). Am J Pathol. 2004; 164: 1645–1653
- Falcon NA, Upton J. Infantile digital fibromas. J Hand Surg. 1995; 20A: 1014–1020
- Rimareix F, Bardot J, Andrac L, Vasse D, Galinier P, Magalon G. Infantile digital fibroma: report of eleven cases. Eur J Pediatr Surg. 1997; 7: 345–348. [PUBMED], [INFOTRIEVE], [CSA]
- Horii E, Sugiura Y, Nakamura R. A syndrome of digital fibromas, facial pigmentary dysplasia, and metacarpal and metatarsal disorganization. Am J Med Gen. 1998; 80: 1–5. [CROSSREF]
- Breuning MH, Oranje AP, Langemeijer RA, et al, Recurrent digital fibroma, focal dermal hypoplasia, and limb malformations. Am J Med Gen. 2000; 94: 91–101. [CROSSREF]
- Dickey GE, Sotelo-Avila C. Fibrous hamartoma of infancy: current review. Pediatr Dev Pathol. 1999; 2: 236–243. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Scott DM, Pena JR, Omura EF. Fibrous hamartoma of infancy. J Am Acad Dermatol. 1999; 41(5 Pt2)857–859. [PUBMED], [INFOTRIEVE], [CSA]
- Halem A, Al-Hindi HN, Al-Juboury M, Al-Husseini H, Al-Ajlan A. Juvenile hyaline fibromatosis: morphologic, immunohistochemical, and ultrastructural study of three siblings. Am J Dermatopathol. 2002; 24: 218–224. [CSA], [CROSSREF]
- Breier F, Fang-Kircher S, Wolff K, Jurecka W. Juvenile hyaline fibromatosis: impaired collagen metabolism in human skin fibroblasts. Arch Dis Child. 1997; 77: 436–440. [PUBMED], [INFOTRIEVE]
- Rahman N, Dunstan M, Teare MD, et al, The gene for juvenile hyaline fibromatosis maps to chromosome 4p21. Am J Hum Genet. 2002; 71: 975–980. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hanks S, Adams S, Douglas J, et al, Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyalinosis fibromatosis and infantile systemic hyalinosis. Am J Hum Genet. 2003; 73: 791–800. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dowling O, Difeo A, Ramirez MC, et al, Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet. 2003; 73: 957–966. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Feldman G, Li, Ming, Martin S, et al, Fibrodysplasia ossficans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4p27-31. Am J Hum Genet. 2000; 66: 128–135. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg. 2004; 12: 116–125. [PUBMED], [INFOTRIEVE], [CSA]
- Blaszczyk M, Majewski S, Brzezinska-Weislo L, Jablonska S. Fibrodysplasia ossificans progressiva. Eur J Dermatol. 2003; 13: 234–237. [PUBMED], [INFOTRIEVE], [CSA]
- Brandao-Paim L, de Lourdes-Liphaus B, da Silva CAA. Fibrodysplasia ossificans progressiva. Indian Pediatr. 2003; 40: 786–788. [CSA]
- Gannon GH, Glaser DL, Caron R, Thompson LD, Shore EM, Kaplan FS. Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol. 2001; 32: 842–848. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Olmsted EA, Kaplan FS, Shore EM. Bone morphogenic protein-4 regulation in fibrodysplasia ossificans progressiva. Clin Orthop. 2003; 408: 331–343. [PUBMED], [INFOTRIEVE]
- Hegyi L, Gannon FH, Glaser DL, Shore EM, Kaplan FS, Shanahan CM. Stromal cells of fibrodysplasia ossificans progressive lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification?. J Pathol. 2003; 201: 141–148. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lucotte G, Barthelier C, Mercier G, et al, Localization of the gene for fibrodysplasia ossificans progressive (FOP) to chromosome 17q21-22. Genet Couns. 2000; 11: 329–334. [PUBMED], [INFOTRIEVE], [CSA]
- Glaser DL, Economides AN, Wang L, et al, In vivo somatic cell gene transfer of an engineered Noggin mutein protein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am. 2003; 85-A: 2332–2342. [PUBMED], [INFOTRIEVE], [CSA]
- Semonin O, Fontaine K, Daviaud C, Ayuso C, Lucotte G. Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressive. Am J Med Genet. 2001; 102: 314–317. [PUBMED], [INFOTRIEVE], [CROSSREF]